| Product Code: ETC6513856 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Brazil continued to rely on key suppliers such as India, China, Italy, USA, and Canada for prostacyclin imports, with a high Herfindahl-Hirschman Index indicating significant market concentration. The compound annual growth rate (CAGR) of 3.78% from 2020-2024 reflects steady expansion, while a growth rate of 1.41% in 2024 suggests ongoing market stability. Import shipments of prostacyclin into Brazil remain crucial for meeting healthcare needs, with these top exporting countries playing a vital role in supplying the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Prostacyclin Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Prostacyclin Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil Prostacyclin Market - Industry Life Cycle |
3.4 Brazil Prostacyclin Market - Porter's Five Forces |
3.5 Brazil Prostacyclin Market Revenues & Volume Share, By Diseases, 2021 & 2031F |
3.6 Brazil Prostacyclin Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Brazil Prostacyclin Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Brazil Prostacyclin Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Brazil Prostacyclin Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Brazil Prostacyclin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brazil Prostacyclin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pulmonary arterial hypertension (PAH) in Brazil |
4.2.2 Growing awareness about prostacyclin therapy as an effective treatment for PAH |
4.2.3 Favorable government initiatives and policies supporting the use of prostacyclin drugs in Brazil |
4.3 Market Restraints |
4.3.1 High cost associated with prostacyclin therapy, limiting access for some patients |
4.3.2 Stringent regulatory requirements for the approval and sale of prostacyclin drugs in Brazil |
5 Brazil Prostacyclin Market Trends |
6 Brazil Prostacyclin Market, By Types |
6.1 Brazil Prostacyclin Market, By Diseases |
6.1.1 Overview and Analysis |
6.1.2 Brazil Prostacyclin Market Revenues & Volume, By Diseases, 2021- 2031F |
6.1.3 Brazil Prostacyclin Market Revenues & Volume, By Pulmonary Arterial Hypertension, 2021- 2031F |
6.1.4 Brazil Prostacyclin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Brazil Prostacyclin Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Brazil Prostacyclin Market Revenues & Volume, By Epoprostenol, 2021- 2031F |
6.2.3 Brazil Prostacyclin Market Revenues & Volume, By Treprostinil, 2021- 2031F |
6.2.4 Brazil Prostacyclin Market Revenues & Volume, By Iloprost, 2021- 2031F |
6.3 Brazil Prostacyclin Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Brazil Prostacyclin Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 Brazil Prostacyclin Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 Brazil Prostacyclin Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Brazil Prostacyclin Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Brazil Prostacyclin Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Brazil Prostacyclin Market Revenues & Volume, By Inhalations, 2021- 2031F |
6.5 Brazil Prostacyclin Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Brazil Prostacyclin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Brazil Prostacyclin Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Brazil Prostacyclin Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6 Brazil Prostacyclin Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Brazil Prostacyclin Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.6.3 Brazil Prostacyclin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.4 Brazil Prostacyclin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.5 Brazil Prostacyclin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Brazil Prostacyclin Market Import-Export Trade Statistics |
7.1 Brazil Prostacyclin Market Export to Major Countries |
7.2 Brazil Prostacyclin Market Imports from Major Countries |
8 Brazil Prostacyclin Market Key Performance Indicators |
8.1 Number of PAH patients prescribed prostacyclin therapy |
8.2 Adoption rate of prostacyclin therapy among healthcare providers |
8.3 Patient satisfaction and adherence rates with prostacyclin treatment |
9 Brazil Prostacyclin Market - Opportunity Assessment |
9.1 Brazil Prostacyclin Market Opportunity Assessment, By Diseases, 2021 & 2031F |
9.2 Brazil Prostacyclin Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Brazil Prostacyclin Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Brazil Prostacyclin Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Brazil Prostacyclin Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Brazil Prostacyclin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brazil Prostacyclin Market - Competitive Landscape |
10.1 Brazil Prostacyclin Market Revenue Share, By Companies, 2024 |
10.2 Brazil Prostacyclin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |